FIELD: chemistry.
SUBSTANCE: invention relates to specific substituted condensed with heterocycle gamma-carbolynam of formula I, where X is -N(H)- or -N(CH3) and Y represents -C(H)(OH)-; and formula III, where X is -N(CH3)-, -N(H)-; and R1 is selected from -C(O)-C-1-5alkyl, -C(O)-C-6alkyl, -C(O)-C7alkyl and -C(O)-C9alkyl in free form, in form of solid substance, in form of pharmaceutically acceptable salts and/or in substantially pure form, as well as to pharmaceutical compositions based on these compounds.
EFFECT: treating diseases involving 5-HT2A receptor, carrier serotonin (SERT) and/or path, involving dopamine D2 receptor system signal.
30 cl, 2 dwg, 2 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2776800C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
NEW METHODS | 2014 |
|
RU2682658C1 |
ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
NEW COMPOSITIONS AND METHODS | 2018 |
|
RU2767410C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
ORGANIC COMPOUNDS | 2014 |
|
RU2679142C2 |
Authors
Dates
2016-07-10—Published
2011-04-22—Filed